Acute Retinal Necrosis: Is The Current Valacyclovir Regimen Adequate?

Abstract

Acute Retinal Necrosis (ARN) is a potentially devastating form of Uveitis. Antivirals are the mainstay treatment for this syndrome. In this letter, we question the current oral Valacyclovir dosage, based on the experience we had with a recent unresponsive ARN case.

• Authors: Gabrielle Senter, Heloisa Moraes Do Nascimento, Rubens Belfort Junior
• Journal: Ocular immunology and inflammation (Ocul Immunol Inflamm) Vol. 28 Issue 4 Pg. 665-666 (May 18 2020) ISSN: 1744-5078 [Electronic] England
• PMID: 31401907 (Publication Type: Case Reports, Letter)

Chemical References

• Antiviral Agents
• Valacyclovir

Topics

• Administration, Oral
• Adult
• Antiviral Agents (administration & dosage)
• Eye Infections, Viral (drug therapy)
• Humans
• Male
• Retinal Necrosis Syndrome, Acute (drug therapy)
• Valacyclovir (administration & dosage)
• Visual Acuity